Non-HACEK gram negative bacilli endocarditis: Analysis of a national prospective cohort.
Jorge Calderón‐Parra(Hospital Universitario Puerta de Hierro Majadahonda), António Ramos, Mercedes Marín Arriaza(Hospital General Universitario Gregorio Marañón), Miguel Ángel Goneaga Sanchez(Biogipuzkoa Health Research Institute), Arístides de Alarcón(Instituto de Biomedicina de Sevilla), Daniel de Castro(Ontario Institute for Cancer Research), Raquel Rodríguez-García(Hospital Universitario Central de Asturias), Guillermo Ojeda(Hospital Clínico Universitario Virgen de la Victoria), Patricia Garcia(Hospital General Universitario Gregorio Marañón), MICHELLE CARRASQUEL ALVAREZ(Marqués de Valdecilla University Hospital), José María Miró Meda(Hospital Clínic de Barcelona), Zeltia Valcarce-Gonzalez(Hospital Universitario Araba), Encarnación Gutiérrez‐Carretero(Hospital Universitario Virgen del Rocío)
Cited by 38
Related Papers
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia
|Journal of Clinical Investigation|2021|110
Preliminary Report on Effects of Photocoagulation Therapy
|American Journal of Ophthalmology|2017|88